Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment
{{output}}
The patient population suffering from pancreatic ductal adenocarcinoma (PDAC) presents, as a whole, with a high degree of molecular tumor heterogeneity. The heterogeneity of PDAC tumor composition has complicated treatment and stalled success in clinical trial... ...
